ORIGINAL PAPER
https://dx.doi.org/10.4314/njpr.v16i2.4S
Nig. J. Pharm. Res. 2020, S1 pp 31-37
ISSN 0189-8434
e-ISSN 2635-3555
Available online at http://www.nigjpharmres.com
Studies on Analgesic and Anti-Inflammatory Activities of Aerial Parts of
Tephrosia Bracteolata GUILL. and PERR. (Fabaceae) in Rodents
A. A. SADAM*1ABCDE, S. M. ABDULLAHI1AEF., U. U. PATEH, 1AF, A. SHEHU2CE, L.O. BAKARE1B
1
Department of Pharmaceutical and Medicinal Chemistry, Ahmadu Bello University, Zaria,
Nigeria.
2
Department of Pharmacology and Therapeutics, Ahmadu Bello University, Zaria, Nigeria
A – research concept and design; B – collection and/or assembly of data; C – data analysis and
interpretation; D – writing the article; E – critical revision of the article; F – final approval of article.
Abstract
Background:Tephrosia bracteolata is a widespread shrub belonging to the family (Fabaceae) and genus Tephrosia.
It is traditionally used for treating rheumatic pains, dropsy and stomach ache.
Objectives:In view of the ethnomedicinal claim and the continuous search for new medicinal agents, the
phytochemical constituents, analgesic and anti-inflammatory activities of chloroform fraction (CF) of the methanol
extract of Tephrosia bracteolata in mice and rats was evaluated.
Methods:Preliminary phytochemical screening was conducted using standard method. Analgesic activity of CF
(100, 200 and 400 mg/kg body weight orally) was investigated using acetic acid-induced writhing test and thermally
induced pain model in mice. Additionally, anti-inflammatory activity was tested by carragenaan-induced paw edema
in rats.
Results:Phytochemical screening revealed the presence of alkaloids, triterpenes and flavonoids. The oral LD 50 of
CF was above 2000 mg/kg body weight. CF significantly (p<0.05) and dose dependently reduced the number of
writhes with percentage inhibition of 47.76 48.41 and 72.6 % at dose of 100, 200 and 400mg/kg respectively. CF
also significantly (p<0.05) and dose dependently increased the mean reaction time. At dose of 400 mg/kg, CF at 60
and 90 minutes exhibited greater activity when compared to the standard agent pentazocine. CF(200 and 400 mg/kg)
at times 3, 4 and 5 hours significantly (p<0.05) decreased the paw edema in rats when compare with the ibuprofen
treated group.
Conclusions:The chloroform fraction of the methanol crude extract of Tephrosia bracteolata possesses analgesic
and anti-inflammatory activities.
Keywords: Tephrosia bracteolata, Phytochemical screening, Toxicity, Analgesic activity, Anti-inflammatory
activity
INTRODUCTION
Medicinal plants have been estimated to be the
primary source of health care needs of over 80% of
the world population living in developing countries
(Gabriel et al., 2018). The process of searching useful
plants from different records to the development of
methods for the industrial production of drugs is
termed Ethnopharmacology and it plays an important
role in the discovery of new biologically active
compounds (Dong., 2013).
Tephrosia bracteolata is a shrub of widespread
belonging to the family Fabaceae that grows in
uncultivated areas of tropical and warm-temperate
regions. There are approximately 400 species
included in this genus (Burkill., 1985). Onaolapo et
al., 2004 reported the toxicity and anti-pyretic studies
of the crude methanolic extract of Tephrosia
bracteolata leaves, the study demonstrated that the
31
Sadam et al./Nig.J.Pharm. Res. 2020, S1:31-37
plant possess potent anti-pyretic activity. Egharevba
et al., 2020 reported the antidiabetic, antioxidant and
antimicrobial activities of extracts of Tephrosia
bracteolata leaves. Other biological activities
reported on other genus of the plant include anticancer (Hassan et al., 2017) and anti-plasmodial
activities (Nondo et al., 2014). Tephrosia genus have
been reported to possess several phytoconstituents
that can be related to various biological activities
including
Isopongaflavone
from
Tephrosia
bracteolata (Khalid et al., 1981), obovatin methyl
ether from Tephrosia aequilata (Atilaw et al., 2017),
kaempferol
3-O-β-D-glucopyranoside
from
Tephrosia calophylla (Ganapaty et al., 2009).
Pain is an ill-defined, unpleasant sensation, usually
evoked by an external and internal noxious stimulus
linked to tissue damage (Chatterjee et al., 2015). It is
physiologically associated with receptors, confirmed
by electrophysiology methods in which the intensity
is dependent on internal or external factors and ends
up in the brain (Yam et al., 2018). Additionally, pain
may also be generated from peripheral and central
METHODOLOGY
Materials
Drugs and reagents
Analytical grade chemicals and reagents were used
including; n-hexane, chloroform, ethyl acetate,
methanol, acetic acid, sulphuric acid (Sigma-Aldrich,
USA), distilled water and tween 80, Molisch’s
reagent, Dragendorff’s reagent, Mayer’s reagent and
Shinoda’s reagent, carrageenan (Sigma Aldrich),
Acetic acid (Searle Essex, England), ibuprofen (Lek,
Slovenia), pentazocine (Martinadale, Essex) and
Piroxicam (Pfizer laboratories).
Experimental animals
Swiss albino mice (20-38 g) and wister rats of either
sex (100-162 g) were obtained from the Animal
House Facility of the Department of Pharmacology
and Therapeutics, Faculty of Pharmaceutical
Sciences, Ahmadu Bello University Zaria, Nigeria.
They were maintained under standard conditions in
propylene cages, fed with laboratory diet and water
ad libitum.
Methods
Plant collection and identification
The aerial parts of the plant (T. bracteolata) was
collected from bushy village of Samaru, Sabon gari
Local Government, Kaduna State, Nigeria in
October, 2018. The plant was authenticated at the
herbarium unit, department of botany, Ahmadu Bello
nervous system (Grichnik et al., 1991). Inflammation
is a complex biological response of the body tissues
to harmful stimuli like pathogens, damaged cell or
irritants (Ferrero-Miliani et al., 2007). The classical
known symptoms of inflammation include redness,
pain, swelling and heat (Medzhitov., 2008). Pain and
inflammation can be classified as acute and chronic.
Analgesics are drugs that selectively relieve pain by
acting on the CNS or peripheral pain mechanisms,
without
significantly
altering
consciousness
(Tripathi., 2003). These drugs have serious limitation
due to their side effects such as gastrointestinal
irritation/ulceration, safety, tolerance, dependency
and respiratory depression (Howland and Mycek.,
2006). Due to these drawbacks, it is necessary to
conceptualize search for newer potent analgesic and
anti-inflammatory agents with better efficacy, lesser
side effects, easily available and accessible.
This study aimed to establish the analgesic and antiinflammatory effect of the aerial part of Tephrosia
bracteolata
University, Zaria by comparing with voucher
specimen number (0385). The aerial part was shade
dried, pounded to powder and stored at room
temperature for use.
Extraction and Partitioning
The pulverized plant material (2 kg) was extracted
exhaustively with methanol using maceration method
for four days with occasional shaking. The extract
was concentrated in-vacuo using rotary evaporator at
40 0C which afforded 190 g greenish-brown crude
methanol extract (CME). Thereafter 150 g of CME
was partitioned with hexane, chloroform and ethyl
acetate in order of polarity to obtain the residual
fractions. The chloroform fraction was utilized for
further study
Phytochemical screening
Preliminary phytochemical screening of the CF
extract was investigated for the presence of alkaloids,
steroids, triterpenes, flavonoids, tannins, glycosides
and flavonoids using standard methods (Trease and
Evans., 1996).
Oral acute toxicity profile
The median lethal dose (LD50) of the CF extract was
conducted according to OECD method (2000) in
mice and rats. In the first phase, 3 animals were
administered the extract with dose 5000 mg/kg body
weight orally. The animals were observed for
mortality within a period of 2 weeks. Thereafter. In
32
Sadam et al./Nig.J.Pharm. Res. 2020, S1:31-37
the second phase, a limit test at one dose level of
2000 mg/kg body weight of the extract is carried out
with 3 animals and observed for signs and symptoms
of toxicity and mortality as stated above. LD50 was
calculated using the formula.
LD50 = 20% 𝑜𝑓 𝑚𝑎𝑥𝑖𝑚𝑢𝑚 𝑡𝑜𝑙𝑒𝑟𝑎𝑡𝑒𝑑 𝑑𝑜𝑠𝑒
Antinociceptive Studies
Acetic acid induced-writhing test in mice
It was conducted according to a method described by
Koster et al (1959). Thirty (30) albino mice of either
% inhibition =
sex were randomly divided into five (5) groups of 6
mice each. Group 1 was administered distilled water
10 ml/kg. Groups 2, 3 and 4 received 100, 200 and
400 mg/kg of the CF extract orally respectively,
while group 5 received piroxicam 10 mg/kg body
weight orally. An hour later, mice in all groups were
administered 10 ml/kg of acetic acid (0.6 % v/v) i.p.
Five minutes latency period was allowed and the
mice were observed for abdominal writhes. The
number of abdominal writhes was counted for a
period of 10 minutes. Percentage inhibition of
writhes was determined using equation 1
Mean number of writhes (control)– Mean number of writhes (test group)
Mean number of writhes (control)
Thermal Induced Pain in Mice
The test was conducted according to the method
described by Eddy & Leimbach (1953). Thirty (30)
mice were divided into 5 groups of 6 mice each. The
first group received distilled water as the negative
control. Groups 2, 3 and 4 were administered with
100, 200 and 400 mg/kg body weight of the CF orally
respectively, while group 5 received 10 mg/kg
pentazocine i.p. An hour later, each mouse was
placed on hot plate (Gallenkamp thermostat) kept at
45±2 ˚C. Reaction time was monitored with stop
watch. Index of pain response latency was calculated
as the time mouse licked its paw or jump up from the
hot plate at time intervals of 30, 60 and 90 minutes
after administration of drug. Baseline reaction time
for each animal was recorded at zero time reading
and a cut off period of 15s was observed to avoid
damage to the paw.
Anti-inflammatory studies
Carragenan-induced paw oedema
Anti-inflammatory study was carried out according to
the method described by Winter et al. (1962).
RESULTS
Preliminary phytochemical screening:
Phytochemical constituents found present in CF were
alkaloids, steroids, triterpenes and flavonoids
Acute toxicity study (LD50)
The oral median lethal dose (LD50) value for CF was
estimated to be greater than 2000 mg/kg body weight.
× 100
…………….
equation
1
Twenty-five (25) rats were divided into 5 groups of 5
rats each. Group 1 received 10 ml/kg of distilled
water orally. Groups 2, 3 and 4 were administered
100, 200 and 400 mg/kg of CF orally respectively
and group 5 received 10 mg/kg of ibuprofen orally.
Thirty minutes later, each rat was injected with 0.01
mL of 1 % v/v solution of carrageenan in the sub
plantar region of the left hind paw. The paw diameter
(cm) was taken at time zero prior to treatment and
subsequently measured at time 1, 2, 3, 4, 5 hours
after injection of carrageenan using vernier caliper.
Statistical Analysis
The data obtained for the acetic acid-induced
writhing test in mice was subjected to one way
analysis of variance (ANOVA) followed by
Dunnett’s Post Hoc test for multiple comparisons.
Also the data obtained for the thermally induce
hyperalgesia and carragenaan-induced paw edema
were analyzed using repeated measures ANOVA
followed by Bonferoni post hoc test for multiple
comparison. Results were considered significant at
P≤0.05 and data was expressed as Mean±SEM.
Acetic Acid Induced Writhing Test
The CF of the methanol aerial extract of T.
bracteolata significantly (P <0.05) attenuated the
acetic acid-induced abdominal writhes in mice dose
dependently. The fraction CF at dose of 400mg/kg
gave highest inhibition of abdominal constriction.
The standard drug piroxicam at dose of 10 mg/kg
significantly (P<0.05) inhibited the acetic acidinduced writhes (Table I).
33
Sadam et al./Nig.J.Pharm. Res. 2020, S1:31-37
Table I: Effect of CF on Acetic Acid Induced Writhing Test in Mice
Treatment
Dose
Mean no. of writhes
(mg/kg)
± SEM
DW
(10 ml/kg)
26.17 ± 5.55
% inhibition
0
CF
100
13.67 ± 3.24*
47.76
CF
200
13.50 ± 1.23*
48.41
CF
400
7.17 ± 1.28*
72.6
Piroxicam
10
4.33 ± 1.33*
83.4
Values presented as Mean ± SEM. Data analyzed using one-way ANOVA followed by Dunett’s PostHoc test.
*Significant at p<0.05when compared with the DW group. n = 6. CF = Chloroform fraction of the T.bracteolata,
DW= Distilled water
Thermal-Induced Pain Test in Mice
CF significantly (p<0.05 and dose dependently
increased the mean reaction time at dose of 400
mg/kg, at time 60- and 90-minute post treatment
(Table II).
Table II: Effect of CF on Thermal-Induced Pain Test in Mice (Hot Plate)
Treatment
Dose (mg/kg)
Mean reaction Time (Seconds) at various time
0mins
30mins
60mins
90mins
DW
10 ml/kg
3.91±0.53
2.33±0.56
1.92±0.37
1.00±0.00
CF
100
3.16±0.32 7.08±1.07*#
CF
200
4.53±0.59
6.45±0.68
7.02±0.83
CF
400
5.96±0.52
7.59±1.12
9.35±1.01 *# 12.36±3.67*#
Penta
10
3.77±0.43
7.91±0.79*
8.47±0.47* 6.87±0.99
6.68±1.05 6.50±1.14
7.61±0.79*
Values presented as Mean ± SEM. Data analysed using Repeated Measures ANOVA followed by Bonferoni’s Post
Hoc test. #Statistically significant difference (p<0.05) in reaction time when compared to pentazocine, *Statistically
significant difference (p<0.05) in reaction time when compared to Distilled water n = 6. Penta = Pentazocine, CF=
Chloroform fraction of the T. bracteolata, DW=Distilled water
Carrageenan-Induced Paw Edema
The fraction at doses of 200 and 400 mg/kg
significantly (p< 0.05) decreased the paw edema size
in rats at time 3, 4- and 5-hours post carrageenan
induction when compared with the distilled treated
group (Table III).
34
Sadam et al./Nig.J.Pharm. Res. 2020, S1:31-37
Table 3: Effect of Chloroform fraction of T.bracteolata on Carragenan-Induced Paw Edema Test in Rat
Treat
Dose
Mean Paw Diameter in cm
ment
(mg/kg)
(% Inhibition)
1h
2h
3h
4h
5h
DW
ml/kg
3.44±0.10
3.56±0.06
3.61±0.13
3.38±0.12 2.82±20.05
CF
100
CF
200
CF
400
Ibu
10
3.22±0.12
(6.39)
2.62±0.2
(19.14)
1.74±0. 10*
(46.29)
1.88±0.21*
(45.35)
3.04±0.17
(14.61)
2.60±0.19*
(26.9)
1.75±0.11
(50.84)
1.86±0.06*
(47.75)
2.61±0.13
(27.70)
2.55±0.14*
(29.36)
1.73±0.03*
(52.08)
1.74±0.08*
(51.80)
2.50±0.13*
(26.04)
2.51±0.1
(25.74)
1.61±0.04*
(52.37)
1.54±0.07*
(54.44)
2.40±0.06*
(14.89)
2.32±0.08*
(17.73)
1.34±0.03*
(52.48)
1.42±0.04*
(49.65)
Values presented as Mean ± SEM. Data were analysed using Repeated Measures ANOVA followed by Bonferoni
post hoc test. * p<0.05 significant difference compared to DW group, n = 5. Ibu = Ibuprofen, CF= Chloroform
fraction of the T.bracteolata, DW= Distilled water.
DISCUSSION
Acetic acid-induced writhing test is a very sensitive
model used for evaluating the peripheral
antinociceptive activity of extract at a very low dose
(Shumaia et al., 2014). The CF in graded doses
administered significantly (p≤0.05) produced
decrease in the number of writhes induced by acetic
acid dose dependently with the highest percentage
inhibition brought by the highest dose respectively.
The intraperitoneal administration of acetic acid
resulted in increased level of prostanoids (PGE 2 and
PGF2α) and lipoxygenases (Derardt et al., 1980) in
the peritoneal fluid thereby stimulating the nerve
endings (pain) through; the release of pain mediators
such as arachidonic acid via cyclooxygenase, the
synthesis of chemo-sensitive niciceptors by
endogenous substances such as bradykinins,
prostaglandins (PGs), serotonin and histamine
(Davies et al., 1984). The model is thought to involve
in part local peritoneal receptors (Bentley et al.,
1983). The CF extract may have interfered with these
peritoneal receptors to bring about analgesia (Musa et
al., 2009). The analgesic activities exhibited by the
CF extract may occur through the process of
inhibiting the production of those algogenic
substances or its action on visceral receptors sensitive
to acetic acid. The extract produced strong analgesic
effect on the acetic acid-induced writhing in the same
order of magnitude as that observed by piroxicam
administration.
Thermally induced hyperalgesia is a specific model
for testing centrally mediated antinociception and the
observed activity is selective for compounds acting
through opioid receptor (Kaushik et al., 2012). The
increase in the mean latency to pain by CF in the
thermally-induced pain in mice suggests that the
extract possesses centrally acting analgesic activity
(Kaushiket al., 2012). At dose of 400 mg/kg, CF at
60 and 90 minutes exhibited greater activity when
compared to the standard agent pentazocine at 10
mg/kg. This suggests that the extract may act via
centrally mediated mechanism (Kaushik et al., 2012).
The extract (100 mg/kg) at 30 minutes produced a
significant effect (p<0.05) on the pain threshold on
the test group when compared to the positive control,
suggesting that the activity of the extract is dose
dependent.
The process of inflammation is multiphasic
including; the increase in vascular permeability,
leucocytes infiltration and the formation of
granuloma. Carrageenan is a phlogistic agent that
induces edema in the paw of experimental animals
used as a model for testing anti-inflammatory
activity (Chatterjee et al., 2015). The early phase (1
hour) of carrageenan induction in the sub-plantar
region of the paw is mediated by the release of
histamine, serotonin and kinins. The late phase (2-3
hours) is mediated by the release of prostaglandins
and lysosome enzymes (Ahmed., 2011).
CF extract contains flavonoids, several derivatives of
flavonoids are known to exhibit anti-inflammatory
and analgesic activities by inhibiting the enzyme
prostaglandin synthetase, more specifically the
endoperoxidase reducing the release of arachidonic
acid (Derardt et al., 1980).
Therefore, the anti-inflammatory activity exhibited
by CF extract may be due to the inhibition of COX1
and COX2 that converts arachidonic acid to PGG2
and PGH2 leading to the production of thromboxane
A2 (Burke et al., 2006). This process is similar to that
of NSAIDs (Roberts and Morrow, 2001) thus
validating the ethnomedical use of the plant in
35
Sadam et al./Nig.J.Pharm. Res. 2020, S1:31-37
achieving analgesia and treating inflammatory
conditions.
The result of the oral acute toxicity study of the CF
extract shows that after the administration of 2000
mg/kg of the extract, no lethality and mortality were
observed. The LD50 was therefore determined to be
2000 mg/kg which is relatively non-toxic. The
phytochemical screening revealed the presence of
alkaloids, triterpenes and flavonoids which may be
responsible for the observed activities (Kaushik et al.,
2012).
The analgesic effect of the extract may be due to the
presence of triterpenes, flavonoids, alkaloids or
saponins (Kaushik et al., 2012).
CONCLUSION
These findings in this experiment substantiated that
the CF of the methanol aerial extract of Tephrosia
bracteolata contain bioactive phytochemicals with
analgesic and anti-inflammatory activities, and
further support the ethnomedical claim of the use of
the plant in the management of pain and
inflammation.
REFERENCES
Ahmed, A. U. (2011). An overview of inflammation: mechanism and consequences. Front Biology. 6(4): 274–281.
Atilaw, Y., Duffy, S., Heydenreich, M., Muiva-Mutisya, L., Avery, V and Erdelyi, M., (2017). A Three Chalconoids
and a Pterocarpene from the Roots of Tephrosia aequilata. Molecules. 22(2): 318.
Bentley, G.A., Newton, S.H and Starr J. (1983). Studies on the anti-nociceptive action of α- agonist drugs and their
interaction with opioid mechanisms. British Journal of Pharmacology. 79: 125-134.
Burke A., Smyth E., FitzGerald G.A.: Analgelsic, Antipyretic agents; pharmacotherapy of Gout. In: Goodman and
Gilman Pharmacological Basis of therapeutics. Eds.: Brunton L.L., Lazo J.S., Parker K.L, McGraw-Hill.,
New York (2006), 11th ed., 671 – 715.
Burkill H.M. (1985). The Useful Plant of West Tropical Africa, Royal Botanical Gardens Kew, 3: 454-457.
Chakraborty, A., Devi, R.K., Rita, S., Sharatchandra, K and Singh, T.I. (2006). Preliminary studies on
antiinflammatory and analgesic activities of Spilanthes acmella in experimental animal models. Indian J.
Pharmacol. 36: 148-150.
Chatterjee, A., Sen, B., Das, S and Chatterjee, T. K. (2015). Anti-inflammatory and Analgesic Activity of
Methanolic Extract of Medicinal Plant Rhodiola rosea l . Rhizomes. International Journal of Pharma
Research and Review. 4(2): 1–8.
Davies, D., Bailey, M., Goldenberg, M. and Ford, H (1984). Genomics of immune diseases and theraphy. Annual
Review of Immunology, 2: 335-357.
Dong, J. (2013). The Relationship between Traditional Chinese Medicine and Modern Medicine. Modern Medicine.
10: 148–153.
Eddy, N.B and Leimbach, D. (1953). Synthetic Analgesics II Dithienylbutenyl and Dithienylbutylamines. Journal
pharmacol Exper Ther. 107: 385-393.
Ferrero, M. L., Nielsen, O. S., Andersen, P. S and Girardin, S. E. (2007). Chronic inflammation: impotance of
NOD2 and NALP3 in interleukinm-1 beta generation. Clinical and Experimental Immunology. 147(2):
227-35.
Gabriel, A. F., Murana, O. O., Sadam, A. A and Babalola, S. A. (2018). Proximate and Heavy Metal Composition
Studies of Chrysophyllum Albidum Seed Cotyledons as a Possible
Animal Feed Additive. Direct
Research Journal of Biology and Biotechnology. 4(2): 22– 26.
Ganapaty, S., Srilakshmi, G.V., Pannakal, S.T., Rahman, H., Laatch,H and Brun, R. (2009b). Cytotoxicity benzyl
and coumestan derivatives from Tephrosia calophulla. Phytochemistry. 70(1): 95-9.
Grichnik K and Ferrante F. (1991). The difference between acute and chronic pain. Mt Sinai J Med. 58(3): 217–220.
Hassan, L., Iqbal, M., Dahham, S., Tabana, Y., Ahamed, M and Majid, A. (2017). Colorectal, prostate and pancreas
human cancers targeted bioassay-guided isolations and characterization of chemical constituents from
Tephrosia apollinea. Med Chem. 17(4): 590–8.
Howland, R.D and Mycek, M.J. (2006). Lippincott’s illustration Review: pharmacology, Harvey, R.A. Champe,
P.C.4th ed., Lippincott Williams and Wilkins Publishers., London, UK, pp 157-168
Khalid, S and Waterman, P. (1981). 8C-Prenylflavonoids from the seed of Tephrosia bracteolata. Phytochemistry.
20(7): 1719-1720.
Kaushik, D., Kumar, A., Kaushik, P and Rana, A.C. (2012). Analgesic and Anti-inflammatory
Activity of Pinus roxburghii Sarg. Advances in Pharmaceutical Sciences. 2012: 15-21.
36
Sadam et al./Nig.J.Pharm. Res. 2020, S1:31-37
Koster, R., Anderson, M. and Beer, E.J., (1959). Acetic acid for analgesic screening. Federation Proceeds. 18: 412–
416.
Medzhitov R. (2008), Origins and Physiological roles of inflammation. Nature. 454 (7203): 428-435.
Musa, A.M, Aliyu, A.B., Yaro, A.H., Magaji, M.G., Hassan, H.S and Abdullahi, M.I. (2009). Preliminary
phytochemical, analgesic and anti-inflammatory studies of the methanolic extract of Anisopusmannii
(N.E.Br) (Asclepiadaceae) in rodents. African Journal of Pharmacy and Pharmacology. 3(8): 374-278.
Nondo, R., Mbwambo, Z., Kidukuli, A., Innocent, E., Mihale, M., Erasto, P., Chen, Y., Yan, T., Gao, C., Cao, W
and Huang, R. (2014). Natural products from the genus Tephrosia. Molecules. 19(2): 1432–58.
Onaolapo, M., Nzelibe, H., Adaudi, A and Ayo, J.O. (2004). Toxicity and anti-pyretic studies of the crude extract
of Tephrosia bracteolata leaves. Journal of phytomedicine and Therapeutics. 9:15-19.
Shumaia, P., Abu Shuaib, R., Abdul, K., Most Afia, A and Tahmida, S. (2014). Phytochemical screening and studies
of analgesic potential of Moring oleifera Lam. stem bark extract on experimental animal model.
International Journal of Phytopharmacy. 4(5): 128-131.
Tripathi, K.D. (2003) Essentials of medical pharmacology. 5th ed., Jaypee Brothers Medical Publishers (P) Ltd.,
New Delhi, India, pp 453.
Winter, E.A., Risley, E.A and Nuss, G.B. (1963). Anti-inflammatory and antipyretic activities of indomethacin. J.
Pharmacol. Exper. Therap.141: 369-376.
Yam, M. F., Chun, Y., Id, L and Tan, C. S. (2018). General Pathways of Pain Sensation and the Major
Neurotransmitters Involved in Pain Regulation. International Journal of Molecular Science. 19: 2164.
*Address for correspondence: Sadam, A.A
Conflict of Interest: None declared
Department of Pharmaceutical and Medicinal Chemistry,
Ahmadu Bello University, Zaria, Nigeria.
Received: October 2020
Accepted: December 2020
Telephone: +2347033185517
E-mails: sadam4rich@gmail.com
37